Business Description
Zai Lab is a China-based biopharmaceutical company founded in 2013 that researches, develops, and sells treatments for cancer, immune disorders, neurological conditions, and infectious diseases. The company markets several approved drugs targeting conditions such as ovarian cancer, lung cancer, pneumonia, and rare neuromuscular diseases. Zai Lab works alongside a number of global pharmaceutical partners, including Pfizer, argenx, and Deciphera, to bring licensed treatments to patients.
